MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bcr-2016-215304

Медицинская библиотека · BMJ case reports · 2016

Battling regional (stage III) lung cancer: bumpy road of a cancer survivor in the immunotherapy age.

Hao Zhonglin, Biddinger Paul, Schroeder Carsten, Tariq Khurram

Клинический случайСтатьяПеревод в очереди

Аннотация

A 58-year-old woman, a heavy smoker, was diagnosed with stage III squamous cell lung cancer. She was treated with concurrent chemotherapy and radiotherapy, with partial response. 2 months later, she had haemoptysis caused by brisk bleeding from the radiated right upper lobe. Fortunately, her bleed was self-limited. 4 months later, a rapidly enlarging renal mass was discovered and turned out to be metastatic from the lung primary. Second-line chemotherapy with docetaxel and ramucirumab did not have effects on the renal mass after 2 cycles. Despite not being eligible for a durvalumab trial because of lack of PD-L1 expression, she had a meaningful response to nivolumab. Once every 2 weeks, infusion of nivolumab resulted in rapid tumour shrinkage in multiple areas. In the next few months, she experienced a variety of side effects, some of which were potentially life-threatening. She had disease progression 9 months into treatment.

Для цитирования: Hao Zhonglin, Biddinger Paul, Schroeder Carsten, Tariq Khurram. Battling regional (stage III) lung cancer: bumpy road of a cancer survivor in the immunotherapy age.. BMJ case reports. 2016. DOI: 10.1136/bcr-2016-215304.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.